|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2002-7-18
|
|
pubmed:abstractText |
We previously reported that stage 3 neuroblastoma comprises (i) a low-risk group including all infants (age 0-11 months) as well as older children with non-abdominal primaries, and (ii) a high-risk group made up of children >1 year of age with abdominal primaries. Aggressive chemotherapy was effective only in the latter group.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:BernardoLL,
pubmed-author:BondGG,
pubmed-author:CarliMM,
pubmed-author:CasaleFF,
pubmed-author:CecchettoGG,
pubmed-author:Di CataldoAA,
pubmed-author:GambiniCC,
pubmed-author:GaraventaAA,
pubmed-author:Italian Cooperative Group for Neuroblastoma,
pubmed-author:Lo PiccoloM SMS,
pubmed-author:ManciniAA,
pubmed-author:MazzoccoKK,
pubmed-author:RizzoAA,
pubmed-author:TonegattiLL,
pubmed-author:ToninoG JGJ,
pubmed-author:di MontezemoloL CLC
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
956-64
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12123342-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12123342-Biopsy, Needle,
pubmed-meshheading:12123342-Child,
pubmed-meshheading:12123342-Child, Preschool,
pubmed-meshheading:12123342-Cyclophosphamide,
pubmed-meshheading:12123342-Dose-Response Relationship, Drug,
pubmed-meshheading:12123342-Doxorubicin,
pubmed-meshheading:12123342-Drug Administration Schedule,
pubmed-meshheading:12123342-Female,
pubmed-meshheading:12123342-Humans,
pubmed-meshheading:12123342-Infant,
pubmed-meshheading:12123342-Infant, Newborn,
pubmed-meshheading:12123342-Male,
pubmed-meshheading:12123342-Neoadjuvant Therapy,
pubmed-meshheading:12123342-Neoplasm Staging,
pubmed-meshheading:12123342-Neuroblastoma,
pubmed-meshheading:12123342-Prognosis,
pubmed-meshheading:12123342-Proportional Hazards Models,
pubmed-meshheading:12123342-Retrospective Studies,
pubmed-meshheading:12123342-Risk Assessment,
pubmed-meshheading:12123342-Survival Analysis,
pubmed-meshheading:12123342-Treatment Outcome,
pubmed-meshheading:12123342-Vincristine
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors.
|
|
pubmed:affiliation |
Department of Hematology--Oncology, Giannina Gaslini Children's Hospital, Genova, Italy. albertogaraventa@ospedale-gaslini.ge.it
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
